USA Compression Partners (USAC) Financials

$24.95 +0.02 (+0.08%)

As of 10:10 AM Eastern

Annual Income Statements for USA Compression Partners

This table shows USA Compression Partners' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	-154	-27	-265	-47	32	-643	-38	-18	20	82
Consolidated Net Income / (Loss)	-154	-27	-265	-11	39	-595	10	30	68	100
Net Income / (Loss) Continuing Operations	-154	-27	-265	-11	80	-595	10	30	68	100
Total Pre-Tax Income	-153	-27	-263	-13	41	-593	11	31	70	102
Total Operating Income	-136	-27	-263	65	168	-465	141	169	232	294
Total Gross Profit	271	264	151	-177	1,169	462	438	470	561	950
Total Revenue	271	264	277	37	1,397	668	633	705	846	950
Operating Revenue	271	264	277	37	1,397	668	633	705	846	950
Total Cost of Revenue	0.00	0.00	125	215	227	206	194	234	285	0.00
Total Operating Expenses	406	291	414	-243	833	927	297	301	329	656
Selling, General & Admin Expense	41	23	25	69	64	60	56	61	73	73
Depreciation Expense	85	155	167	214	231	239	239	237	246	265
Other Operating Expenses / (Income)	82	113	0.00	-547	530	-	-	-	-	313
Impairment Charge	199	-	223	8.67	5.89	628	5.12	1.49	12	0.91
Other Special Charges / (Income)	-1.04	0.12	-0.37	13	0.94	0.15	-2.59	1.53	-1.67	4.94
Total Other Income / (Expense), net	-18	-0.15	-0.22	-78	-254	-129	-130	-138	-162	-193
Interest Expense	18	-	0.00	78	127	129	130	138	170	198
Interest & Investment Income	-	-	-	-	-	-	0.00	0.00	7.45	5.68
Other Income / (Expense), net	0.02	-0.15	-0.22	0.04	-127	0.09	0.11	0.09	0.13	0.11
Income Tax Expense	1.09	-0.16	1.84	-2.47	2.19	1.33	0.87	1.02	1.37	2.23
Preferred Stock Dividends Declared	-	-	0.00	36	49	49	49	49	48	18
Basic Earnings per Share	-	-	-	($2.76)	-	($6.65)	($0.40)	($0.19)	$0.21	$0.72
Weighted Average Basic Shares Outstanding	34.11M	-8.40M	62.19M	0.00	0.00	96.82M	97.07M	97.78M	98.63M	113.39M
Diluted Earnings per Share	-	-	-	($2.76)	-	($6.65)	($0.40)	($0.19)	$0.20	$0.72
Weighted Average Diluted Shares Outstanding	34.11M	-8.40M	62.19M	0.00	0.00	96.82M	97.07M	97.78M	100.68M	114.50M
Weighted Average Basic & Diluted Shares Outstanding	47.90M	-8.40M	62.19M	80.88M	0.00	96.82M	97.07M	97.78M	98.63M	113.39M
Cash Dividends to Common per Share	$2.09	$2.10	$2.10	$1.58	$2.10	$2.10	$2.10	$2.10	$2.10	$2.10

This table shows USA Compression Partners' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	-2.58	-3.82	-1.25	11	8.71	1.63	19	27	15	21
Consolidated Net Income / (Loss)	9.61	8.37	11	24	21	13	24	31	19	25
Net Income / (Loss) Continuing Operations	9.61	8.37	11	24	21	13	24	31	19	25
Total Pre-Tax Income	9.99	8.73	11	24	21	13	24	32	20	26
Total Operating Income	45	47	51	51	61	69	67	77	76	75
Total Gross Profit	120	124	130	137	142	152	154	157	158	481
Total Revenue	180	190	197	207	217	225	229	235	240	246
Operating Revenue	180	190	197	207	217	225	229	235	240	246
Total Cost of Revenue	59	66	67	70	75	73	75	78	82	-235
Total Operating Expenses	75	77	79	86	81	83	87	80	82	406
Selling, General & Admin Expense	15	17	19	15	20	19	23	14	15	20
Depreciation Expense	59	60	59	60	64	62	63	65	67	69
Impairment Charge	0.50	0.55	1.19	10	0.88	-	0.00	0.31	0.00	0.60
Other Special Charges / (Income)	1.12	-0.44	-0.38	0.31	-3.87	2.27	1.25	-0.02	-0.12	3.83
Total Other Income / (Expense), net	-35	-38	-40	-27	-40	-55	-43	-46	-56	-49
Interest Expense	35	38	40	42	43	45	52	49	49	49
Other Income / (Expense), net	0.03	0.02	0.02	0.06	3.46	-3.41	0.03	0.03	-6.20	6.25
Income Tax Expense	0.38	0.36	0.35	0.41	0.26	0.36	0.47	0.46	0.79	0.50
Preferred Stock Dividends Declared	12	12	12	12	12	11	4.39	4.39	4.39	4.39
Basic Earnings per Share	($0.03)	($0.04)	($0.01)	$0.12	$0.09	$0.01	$0.19	$0.23	$0.13	$0.17
Weighted Average Basic Shares Outstanding	97.97M	97.78M	98.25M	98.27M	98.29M	98.63M	102.54M	116.85M	117.02M	113.39M
Diluted Earnings per Share	($0.03)	($0.04)	($0.01)	$0.11	$0.09	$0.01	$0.19	$0.23	$0.13	$0.17
Weighted Average Diluted Shares Outstanding	97.97M	97.78M	98.25M	99.69M	100.26M	100.68M	103.61M	117.97M	118.26M	114.50M
Weighted Average Basic & Diluted Shares Outstanding	97.97M	97.78M	98.25M	98.27M	98.29M	98.63M	102.54M	116.85M	117.02M	113.39M
Cash Dividends to Common per Share	$0.53	$0.53	$0.53	$0.53	$0.53	$0.53	$0.53	$0.53	$0.53	$0.53

This table details how cash moves in and out of USA Compression Partners' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	0.00	2.93	-10	-3.91	-0.09	-0.01	-0.00	0.04	-0.02	0.00
Net Cash From Operating Activities	117	130	136	226	301	293	265	261	272	341
Net Cash From Continuing Operating Activities	117	130	136	226	301	293	265	259	272	340
Net Income / (Loss) Continuing Operations	-154	-27	-265	-11	39	-595	10	30	68	100
Consolidated Net Income / (Loss)	-154	-27	-265	-11	39	-595	10	30	68	100
Depreciation Expense	85	155	167	214	231	239	239	237	246	265
Amortization Expense	1.70	-	0.00	5.08	7.61	8.40	9.77	7.27	7.28	8.75
Non-Cash Adjustments To Reconcile Net Income	202	3.07	225	34	19	640	15	17	34	27
Changes in Operating Assets and Liabilities, net	-18	-1.19	9.23	-16	3.70	0.81	-8.74	-32	-84	-60
Net Cash From Investing Activities	-278	-37	-142	-780	-144	-105	-39	-130	-233	-202
Net Cash From Continuing Investing Activities	-278	-37	-142	-780	-144	-105	-39	-130	-233	-202
Purchase of Property, Plant & Equipment	-281	-62	-157	-267	-171	-109	-45	-134	-239	-205
Sale of Property, Plant & Equipment	1.74	25	15	7.47	22	2.65	4.47	3.68	5.33	1.34
Other Investing Activities, net	1.16	-	0.00	0.41	4.18	1.32	1.56	0.60	0.54	1.50
Net Cash From Financing Activities	161	-90	-3.67	549	-156	-188	-226	-131	-39	-139
Net Cash From Continuing Financing Activities	161	-90	0.00	549	-156	-188	-226	-131	-39	-139
Repayment of Debt	-349	-	0.00	-485	-1,499	-711	-666	-715	-864	-1,218
Repurchase of Preferred Equity	-	-	0.00	-	-244	-253	-255	-257	-258	-267
Issuance of Debt	480	-	0.00	698	750	777	698	0.00	1,089	1,000
Issuance of Common Equity	75	-	-	-	852	-	-	845	-	1,118
Other Financing Activities, net	-0.21	-	0.00	24	-15	-1.13	-3.17	-3.51	-6.45	-773
Cash Interest Paid	17	-	0.00	61	105	121	121	129	164	154
Cash Income Taxes Paid	0.28	-	0.00	0.18	0.49	0.63	0.82	0.89	1.15	1.46

This table details how cash moves in and out of USA Compression Partners' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	0.01	0.03	-0.03	0.03	-0.03	0.01	-0.00	0.00	0.07	-0.07
Net Cash From Operating Activities	49	82	42	88	50	92	66	97	48	130
Net Cash From Continuing Operating Activities	49	81	42	88	50	92	66	97	48	129
Net Income / (Loss) Continuing Operations	9.61	8.37	11	24	21	13	24	31	19	25
Consolidated Net Income / (Loss)	9.61	8.37	11	24	21	13	24	31	19	25
Depreciation Expense	59	60	59	60	64	62	63	65	67	69
Amortization Expense	1.81	1.81	1.82	1.82	1.82	1.82	2.00	2.26	2.25	2.25
Non-Cash Adjustments To Reconcile Net Income	4.63	4.80	7.59	13	5.04	8.28	14	0.86	2.55	9.70
Changes in Operating Assets and Liabilities, net	-26	5.75	-38	-11	-42	6.19	-37	-2.92	-43	23
Net Cash From Investing Activities	-44	-44	-41	-64	-48	-79	-99	-48	-28	-27
Net Cash From Continuing Investing Activities	-44	-44	-41	-64	-48	-79	-99	-48	-28	-27
Purchase of Property, Plant & Equipment	-44	-46	-41	-65	-53	-79	-99	-49	-29	-29
Sale of Property, Plant & Equipment	0.29	2.63	0.54	0.56	4.03	0.21	0.04	0.40	0.31	0.60
Other Investing Activities, net	0.41	-	-	-	-	-	-	-	-	1.50
Net Cash From Financing Activities	-5.66	-39	-1.51	-23	-2.02	-12	33	-49	-20	-103
Net Cash From Continuing Financing Activities	-5.66	-39	-1.51	-23	-2.02	-12	33	-49	-20	-103
Repayment of Debt	-181	-193	-203	-205	-224	-232	-478	-240	-251	-250
Repurchase of Preferred Equity	-	-	-64	-	-	-64	-	-	-	-68
Issuance of Debt	241	-623	266	245	287	291	1,325	257	297	-880
Other Financing Activities, net	-	-2.46	-0.25	0.25	-	-6.45	-749	-	-	-24
Cash Interest Paid	58	10	63	15	68	18	45	16	77	16

This table presents USA Compression Partners' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	1,510	1,472	1,719	3,775	3,730	2,949	2,768	2,666	2,737	2,746
Total Current Assets	53	73	74	218	231	200	205	186	226	235
Cash & Equivalents	0.01	0.07	4.01	0.10	0.01	0.00	0.00	0.04	0.01	0.01
Accounts Receivable	31	41	33	127	137	112	113	84	95	89
Inventories, net	19	30	33	89	92	85	86	94	115	134
Prepaid Expenses	2.60	2.08	4.21	1.59	2.20	2.44	6.02	8.78	11	12
Other Current Assets	-	-	-	-	-	-	-	0.00	5.67	0.00
Plant, Property, & Equipment, net	1,318	1,268	1,193	2,521	0.00	0.00	0.00	0.00	0.00	0.00
Total Noncurrent Assets	139	132	452	1,035	3,499	2,749	2,563	2,479	2,510	2,511
Intangible Assets	79	75	198	393	363	334	304	275	246	216
Other Noncurrent Operating Assets	6.85	6.74	0.21	23	2,517	2,415	2,259	2,204	2,265	2,294
Total Liabilities & Shareholders' Equity	1,510	1,472	1,719	4,676	3,730	2,949	2,869	2,666	2,737	2,746
Total Liabilities	1,510	1,472	54	1,918	2,073	2,134	2,190	2,305	2,554	2,718
Total Current Liabilities	61	56	47	150	189	170	188	174	188	191
Accounts Payable	24	13	3.36	24	22	14	23	35	40	27
Accrued Expenses	21	27	42	94	119	110	114	76	85	99
Current Deferred Revenue	17	17	2.22	31	48	47	51	62	63	64
Total Noncurrent Liabilities	1,448	1,416	6.99	1,769	1,883	1,963	2,002	2,131	2,366	2,527
Long-Term Debt	729	685	-	1,759	1,852	1,927	1,973	2,107	2,336	2,503
Other Noncurrent Operating Liabilities	719	731	6.99	9.83	31	36	29	24	30	25
Commitments & Contingencies	-	-	-	-	0.00	0.00	-	0.00	0.00	0.00
Redeemable Noncontrolling Interest	-	-	1,665	2,758	477	477	578	477	476	169
Total Equity & Noncontrolling Interests	0.00	0.00	0.00	0.00	1,181	338	101	-116	-293	-141
Total Preferred & Common Equity	0.00	0.00	0.00	0.00	1,181	338	101	-116	-293	-141
Total Common Equity	0.00	0.00	0.00	0.00	1,181	338	101	-116	-293	-141
Common Stock	-	-	-	-	1,167	324	-	-125	-293	-141

This table presents USA Compression Partners' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	2,673	2,658	2,691	2,706	2,804	2,822	2,804
Total Current Assets	180	186	212	224	249	256	262
Cash & Equivalents	0.01	0.01	0.03	0.01	0.01	0.01	0.08
Accounts Receivable	80	80	90	97	102	106	106
Inventories, net	92	96	101	106	129	131	147
Prepaid Expenses	8.76	9.13	10	9.16	11	11	9.26
Other Current Assets	-	-	10	11	7.17	7.18	0.00
Plant, Property, & Equipment, net	2,178	0.00	0.00	0.00	0.00	0.00	0.00
Total Noncurrent Assets	315	2,472	2,479	2,483	2,555	2,566	2,541
Intangible Assets	282	268	260	253	238	231	224
Other Noncurrent Operating Assets	33	2,204	2,219	2,230	2,317	2,335	2,318
Total Liabilities & Shareholders' Equity	2,673	2,489	2,691	2,706	2,804	2,822	2,804
Total Liabilities	2,261	2,349	2,422	2,480	2,662	2,714	2,742
Total Current Liabilities	158	156	187	178	174	205	183
Accounts Payable	39	39	37	37	34	36	32
Accrued Expenses	59	55	88	78	74	103	84
Current Deferred Revenue	60	62	63	63	65	66	68
Total Noncurrent Liabilities	2,580	2,193	2,234	2,302	2,489	2,509	2,559
Long-Term Debt	2,078	2,170	2,213	2,276	2,463	2,484	2,532
Other Noncurrent Operating Liabilities	502	23	22	26	26	25	27
Commitments & Contingencies	0.00	-	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	-	309	477	477	431	169	169
Total Equity & Noncontrolling Interests	-65	-168	-208	-251	-290	-61	-107
Total Preferred & Common Equity	-65	-168	-208	-251	-290	-61	-107
Total Common Equity	-65	-168	-208	-251	-290	-61	-107
Common Stock	-74	-	-217	-259	-290	-61	-107

This table displays calculated financial ratios and metrics derived from USA Compression Partners' official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	22.14%	-2.44%	4.82%	-86.46%	3,628.99%	-52.20%	-5.25%	11.37%	20.09%	12.32%
EBITDA Growth	-144.24%	363.20%	-175.24%	394.94%	-1.29%	-177.52%	279.17%	6.11%	17.46%	17.01%
EBIT Growth	-460.80%	80.01%	-869.83%	124.86%	-36.65%	-1,222.68%	130.33%	20.15%	37.03%	26.91%
NOPAT Growth	-353.72%	80.12%	-874.50%	124.86%	248.83%	-304.04%	139.90%	26.17%	38.85%	26.63%
Net Income Growth	-718.43%	82.53%	-882.53%	96.01%	470.88%	-1,619.81%	101.73%	194.95%	125.17%	45.86%
EPS Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	93.99%	52.50%	205.26%	260.00%
Operating Cash Flow Growth	125.78%	10.79%	4.53%	66.48%	32.80%	-2.46%	-9.47%	-1.82%	4.33%	25.54%
Free Cash Flow Firm Growth	-68.26%	110.91%	-4,736.52%	-64.61%	113.85%	67.55%	-27.71%	-22.59%	-29.01%	57.35%
Invested Capital Growth	22.58%	-6.02%	142.35%	117.67%	-2.90%	-21.89%	-6.94%	-3.29%	2.09%	0.44%
Revenue Q/Q Growth	2.90%	1.66%	-0.27%	-92.27%	859.60%	-51.59%	-34.57%	4.47%	4.31%	2.24%
EBITDA Q/Q Growth	-141.83%	441.81%	-166.96%	1,472.31%	-29.59%	34.86%	1.35%	2.46%	4.52%	4.13%
EBIT Q/Q Growth	-530.76%	79.11%	-301.45%	129.53%	-74.32%	19.76%	3.79%	6.52%	8.62%	5.61%
NOPAT Q/Q Growth	-401.58%	79.24%	-302.64%	129.53%	-1.60%	-2.79%	11.43%	6.93%	10.56%	2.23%
Net Income Q/Q Growth	-1,213.32%	82.03%	-363.41%	96.02%	-2.26%	-1.84%	80.33%	21.00%	7.01%	14.48%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	6.98%	24.00%	33.33%	28.57%
Operating Cash Flow Q/Q Growth	36.01%	-7.08%	2.41%	31.69%	-0.48%	2.03%	-5.85%	0.40%	3.62%	12.75%
Free Cash Flow Firm Q/Q Growth	-33.10%	-95.98%	-45.72%	37.13%	10.35%	8.07%	-8.11%	-66.35%	161.86%	44.95%
Invested Capital Q/Q Growth	2.21%	63,649.40%	121.13%	-0.47%	-1.25%	-3.05%	-1.72%	22.58%	0.64%	-2.45%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	100.00%	100.00%	54.75%	-473.27%	83.73%	69.16%	69.27%	66.74%	66.35%	100.00%
EBITDA Margin	-17.98%	48.51%	-34.82%	758.55%	20.08%	-32.56%	61.57%	58.66%	57.37%	59.77%
Operating Margin	-50.12%	-10.21%	-94.94%	174.37%	12.06%	-69.62%	22.27%	24.03%	27.42%	30.98%
EBIT Margin	-50.11%	-10.27%	-95.02%	174.48%	2.96%	-69.61%	22.28%	24.04%	27.43%	30.99%
Profit (Net Income) Margin	-57.02%	-10.21%	-95.69%	-28.17%	2.80%	-89.07%	1.62%	4.30%	8.07%	10.48%
Tax Burden Percent	100.71%	99.40%	100.70%	81.01%	94.71%	100.22%	92.16%	96.76%	98.04%	97.81%
Interest Burden Percent	112.98%	100.00%	100.00%	-19.93%	99.81%	127.68%	7.91%	18.50%	30.00%	34.56%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	5.29%	0.00%	7.84%	3.24%	1.96%	2.19%
Return on Invested Capital (ROIC)	-14.34%	-2.67%	-15.67%	1.73%	4.48%	-10.41%	4.91%	6.53%	9.12%	11.41%
ROIC Less NNEP Spread (ROIC-NNEP)	-23.30%	-3.81%	-39.41%	-11.45%	-4.41%	-24.66%	-1.39%	-0.18%	1.96%	3.62%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	-16.13%	-2.21%	-2.70%	-37.69%	-3.53%	-0.70%	15.97%	83.06%
Return on Equity (ROE)	0.00%	0.00%	-31.80%	-0.48%	1.77%	-48.10%	1.38%	5.83%	25.10%	94.47%
Cash Return on Invested Capital (CROIC)	-34.63%	3.54%	-98.84%	-72.35%	7.42%	14.17%	12.10%	9.88%	7.06%	10.96%
Operating Return on Assets (OROA)	-8.96%	-1.82%	-16.48%	2.38%	1.10%	-13.92%	4.93%	6.23%	8.59%	10.75%
Return on Assets (ROA)	-10.20%	-1.81%	-16.59%	-0.38%	1.04%	-17.81%	0.36%	1.12%	2.53%	3.63%
Return on Common Equity (ROCE)	0.00%	0.00%	0.00%	0.00%	0.47%	-29.53%	0.40%	-0.09%	-18.89%	-194.64%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	0.00%	0.00%	3.31%	-176.14%	10.17%	-26.07%	-23.28%	-70.60%
Net Operating Profit after Tax (NOPAT)	-95	-19	-184	46	159	-325	130	164	227	288
NOPAT Margin	-35.09%	-7.15%	-66.46%	122.06%	11.42%	-48.74%	20.52%	23.25%	26.88%	30.30%
Net Nonoperating Expense Percent (NNEP)	8.96%	1.14%	23.74%	13.19%	8.88%	14.25%	6.29%	6.71%	7.17%	7.79%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	8.23%	11.13%	12.20%
Cost of Revenue to Revenue	0.00%	0.00%	45.25%	573.27%	16.27%	30.84%	30.73%	33.26%	33.65%	0.00%
SG&A Expenses to Revenue	15.14%	8.62%	9.02%	184.20%	4.61%	8.98%	8.86%	8.70%	8.59%	7.65%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	150.12%	110.21%	149.69%	-647.64%	59.61%	138.78%	47.01%	42.72%	38.94%	69.02%
Earnings before Interest and Taxes (EBIT)	-136	-27	-263	65	41	-465	141	169	232	295
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-49	128	-96	284	280	-217	390	413	485	568
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	2.71	13.23	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	236.72	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.50	-0.22	1.69	0.00	0.00	1.37	2.11	2.21	2.44	2.78
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	100.66	32.23
Dividend Yield	52.06%	30.25%	28.00%	31.56%	19.99%	22.23%	15.24%	13.20%	10.25%	9.10%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.99%	3.10%
Enterprise Value to Invested Capital (EV/IC)	1.19	0.00	1.28	0.00	0.00	1.21	1.52	1.68	1.94	2.10
Enterprise Value to Revenue (EV/Rev)	3.20	0.00	7.69	0.00	0.00	4.97	6.15	5.88	5.76	5.59
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	9.99	10.02	10.04	9.36
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	27.59	24.44	21.00	18.04
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	29.96	25.27	21.44	18.45
Enterprise Value to Operating Cash Flow (EV/OCF)	7.37	0.00	15.65	0.00	0.00	11.32	14.65	15.89	17.93	15.57
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	7.49	12.15	16.70	27.71	19.20
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.64	1.12	2.36	2.90	5.84	12.76	90.16
Long-Term Debt to Equity	0.00	0.00	0.00	0.64	1.12	2.36	2.90	5.84	12.76	90.16
Financial Leverage	0.00	0.00	0.41	0.19	0.61	1.53	2.54	3.82	8.17	22.95
Leverage Ratio	0.00	0.00	1.92	1.24	1.70	2.70	3.83	5.22	9.93	26.01
Compound Leverage Factor	0.00	0.00	1.92	-0.25	1.70	3.45	0.30	0.97	2.98	8.99
Debt to Total Capital	100.00%	100.00%	0.00%	38.95%	52.77%	70.28%	74.38%	85.37%	92.73%	98.90%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	100.00%	100.00%	0.00%	38.95%	52.77%	70.28%	74.38%	85.37%	92.73%	98.90%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	100.00%	61.06%	13.60%	17.41%	21.80%	19.34%	18.91%	6.67%
Common Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	33.63%	12.31%	3.81%	-4.71%	-11.64%	-5.57%
Debt to EBITDA	-14.99	5.35	0.00	6.19	6.60	-8.86	5.07	5.10	4.81	4.41
Net Debt to EBITDA	-14.99	5.35	0.00	6.19	6.60	-8.86	5.07	5.10	4.81	4.41
Long-Term Debt to EBITDA	-14.99	5.35	0.00	6.19	6.60	-8.86	5.07	5.10	4.81	4.41
Debt to NOPAT	-7.68	-36.32	0.00	38.48	11.62	-5.92	15.20	12.86	10.27	8.69
Net Debt to NOPAT	-7.68	-36.32	0.00	38.47	11.62	-5.92	15.20	12.86	10.27	8.69
Long-Term Debt to NOPAT	-7.68	-36.32	0.00	38.48	11.62	-5.92	15.20	12.86	10.27	8.69
Altman Z-Score	-0.07	0.00	4.85	0.00	0.00	-0.02	0.77	0.88	1.09	1.30
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	100.00%	100.00%	73.26%	38.60%	70.64%	101.46%	175.28%	306.03%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.86	1.29	1.58	1.46	1.22	1.17	1.09	1.07	1.21	1.23
Quick Ratio	0.51	0.73	0.78	0.85	0.72	0.66	0.60	0.48	0.51	0.47
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-229	25	-1,159	-1,909	264	443	320	248	176	277
Operating Cash Flow to CapEx	42.03%	353.75%	95.44%	87.36%	202.18%	275.50%	651.40%	199.62%	116.59%	167.72%
Free Cash Flow to Firm to Interest Expense	-13.02	0.00	0.00	-24.35	2.08	3.44	2.47	1.80	1.04	1.40
Operating Cash Flow to Interest Expense	6.67	0.00	0.00	2.89	2.36	2.28	2.04	1.89	1.60	1.72
Operating Cash Flow Less CapEx to Interest Expense	-9.20	0.00	0.00	-0.42	1.19	1.45	1.73	0.94	0.23	0.69
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.18	0.18	0.17	0.01	0.37	0.20	0.22	0.26	0.31	0.35
Accounts Receivable Turnover	9.08	7.26	7.48	0.47	10.59	5.36	5.61	7.15	9.44	10.30
Inventory Turnover	0.00	0.00	3.99	3.51	2.51	2.33	2.28	2.61	2.73	0.00
Fixed Asset Turnover	0.22	0.20	0.22	0.02	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	0.00	0.00	15.17	15.58	9.90	11.69	10.78	8.10	7.58	0.00
Days Sales Outstanding (DSO)	40.19	50.31	48.82	778.52	34.47	68.13	65.09	51.03	38.67	35.43
Days Inventory Outstanding (DIO)	0.00	0.00	91.51	103.89	145.27	156.46	160.02	139.85	133.64	0.00
Days Payable Outstanding (DPO)	0.00	0.00	24.06	23.42	36.85	31.22	33.86	45.05	48.13	0.00
Cash Conversion Cycle (CCC)	40.19	50.31	116.26	858.99	142.89	193.37	191.25	145.84	124.18	35.43
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	729	685	1,661	3,615	3,510	2,742	2,552	2,468	2,519	2,530
Invested Capital Turnover	0.41	0.37	0.24	0.01	0.39	0.21	0.24	0.28	0.34	0.38
Increase / (Decrease) in Invested Capital	134	-44	976	1,954	-105	-768	-190	-84	52	11
Enterprise Value (EV)	865	0.00	2,127	0.00	0.00	3,319	3,890	4,140	4,875	5,315
Market Capitalization	136	-58	467	0.00	0.00	915	1,338	1,556	2,063	2,644
Book Value per Share	$0.00	$0.00	$0.00	$0.00	$12.22	$3.48	$1.04	($1.19)	($2.98)	($1.21)
Tangible Book Value per Share	($2.22)	($2.01)	($7.28)	($10.50)	$2.05	$0.04	($2.09)	($3.99)	($5.48)	($3.05)
Total Capital	729	685	1,665	4,517	3,510	2,742	2,653	2,468	2,519	2,530
Total Debt	729	685	0.00	1,759	1,852	1,927	1,973	2,107	2,336	2,503
Total Long-Term Debt	729	685	0.00	1,759	1,852	1,927	1,973	2,107	2,336	2,503
Net Debt	729	685	-4.01	1,759	1,852	1,927	1,973	2,107	2,336	2,503
Capital Expenditures (CapEx)	279	37	142	259	149	106	41	131	233	204
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-8.46	16	23	68	42	29	17	13	39	44
Debt-free Net Working Capital (DFNWC)	-8.46	17	27	68	42	29	17	13	39	44
Net Working Capital (NWC)	-8.46	17	27	68	42	29	17	13	39	44
Net Nonoperating Expense (NNE)	59	8.08	81	56	120	269	120	133	159	188
Net Nonoperating Obligations (NNO)	729	685	-4.01	857	1,852	1,927	1,872	2,107	2,336	2,503
Total Depreciation and Amortization (D&A)	87	155	167	219	239	247	249	244	253	274
Debt-free, Cash-free Net Working Capital to Revenue	-3.13%	6.25%	8.34%	181.66%	2.97%	4.39%	2.74%	1.81%	4.60%	4.66%
Debt-free Net Working Capital to Revenue	-3.13%	6.27%	9.79%	181.92%	2.97%	4.39%	2.74%	1.81%	4.60%	4.66%
Net Working Capital to Revenue	-3.13%	6.27%	9.79%	181.92%	2.97%	4.39%	2.74%	1.81%	4.60%	4.66%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($3.15)	$0.00	$0.00	$0.00	($2.15)	($6.65)	$0.00	($0.19)	$0.21	$0.72
Adjusted Weighted Average Basic Shares Outstanding	34.11M	53.04K	61.56M	96.40M	96.65M	97.00M	97.38M	97.78M	98.63M	113.39M
Adjusted Diluted Earnings per Share	($3.15)	$0.00	$0.00	$0.00	($2.15)	($6.65)	$0.00	($0.19)	$0.20	$0.72
Adjusted Weighted Average Diluted Shares Outstanding	34.11M	53.34K	61.84M	96.40M	96.65M	97.00M	97.38M	97.78M	100.68M	114.50M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	($2.15)	($6.65)	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	52.60M	60.69M	62.19M	96.40M	96.59M	96.82M	97.38M	97.78M	98.63M	113.39M
Normalized Net Operating Profit after Tax (NOPAT)	44	-19	-28	61	166	114	132	167	238	294
Normalized NOPAT Margin	16.25%	-7.12%	-10.13%	162.48%	11.88%	17.07%	20.89%	23.66%	28.12%	30.90%
Pre Tax Income Margin	-56.62%	-10.27%	-95.02%	-34.77%	2.96%	-88.87%	1.76%	4.45%	8.23%	10.71%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-7.70	0.00	0.00	0.83	0.33	-3.61	1.09	1.23	1.37	1.48
NOPAT to Interest Expense	-5.39	0.00	0.00	0.58	1.25	-2.53	1.00	1.19	1.34	1.45
EBIT Less CapEx to Interest Expense	-23.57	0.00	0.00	-2.47	-0.84	-4.44	0.77	0.28	-0.01	0.46
NOPAT Less CapEx to Interest Expense	-21.26	0.00	0.00	-2.72	0.09	-3.36	0.69	0.24	-0.03	0.43
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-29.22%	-335.39%	0.00%	-1,578.68%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-29.22%	-335.39%	0.00%	-1,578.68%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from USA Compression Partners' official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	13.23%	18.86%	20.63%	20.68%	20.86%	18.38%	16.31%	13.72%	10.54%	9.26%
EBITDA Growth	7.65%	10.06%	17.07%	9.83%	23.29%	19.38%	17.58%	27.90%	6.63%	17.43%
EBIT Growth	23.14%	28.50%	45.46%	21.37%	42.73%	39.41%	30.98%	50.33%	7.87%	24.02%
NOPAT Growth	27.48%	34.49%	42.09%	22.59%	38.74%	48.98%	32.51%	50.80%	20.71%	9.57%
Net Income Growth	133.58%	169.44%	236.23%	159.56%	117.46%	53.49%	115.46%	32.45%	-7.54%	98.09%
EPS Growth	62.50%	60.00%	88.89%	466.67%	400.00%	125.00%	2,000.00%	109.09%	44.44%	1,600.00%
Operating Cash Flow Growth	8.64%	1.29%	20.78%	-6.75%	1.75%	11.58%	55.69%	10.09%	-3.18%	42.13%
Free Cash Flow Firm Growth	135.67%	-42.40%	-44.54%	-164.77%	-168.60%	-88.20%	-153.01%	92.12%	95.80%	307.37%
Invested Capital Growth	-22.47%	-3.29%	-2.47%	23.77%	24.35%	2.09%	5.05%	4.42%	3.63%	0.44%
Revenue Q/Q Growth	4.75%	5.85%	3.69%	4.97%	4.91%	3.67%	1.88%	2.63%	1.98%	2.47%
EBITDA Q/Q Growth	2.44%	2.55%	3.67%	0.85%	14.99%	-0.70%	-0.53%	9.70%	-4.14%	9.36%
EBIT Q/Q Growth	6.39%	3.51%	9.34%	0.79%	25.11%	1.11%	-2.42%	15.68%	-10.23%	16.25%
NOPAT Q/Q Growth	5.25%	3.15%	10.50%	2.19%	19.11%	10.76%	-1.71%	16.29%	-4.65%	0.54%
Net Income Q/Q Growth	5.79%	-12.96%	30.78%	115.56%	-11.37%	-38.57%	83.58%	32.52%	-38.13%	31.61%
EPS Q/Q Growth	0.00%	-33.33%	75.00%	1,200.00%	-18.18%	-88.89%	1,800.00%	21.05%	-43.48%	30.77%
Operating Cash Flow Q/Q Growth	-47.78%	66.84%	-48.43%	107.55%	-43.02%	82.94%	-28.04%	46.76%	-49.89%	168.55%
Free Cash Flow Firm Q/Q Growth	-4.73%	-79.45%	-12.80%	-479.37%	-0.91%	103.53%	-491.72%	43.62%	46.22%	442.99%
Invested Capital Q/Q Growth	0.39%	22.58%	0.47%	0.11%	0.86%	0.64%	3.38%	-0.49%	0.08%	-2.45%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	66.90%	65.29%	66.18%	66.21%	65.48%	67.48%	67.26%	66.78%	65.91%	195.59%
EBITDA Margin	58.86%	57.03%	57.01%	54.78%	60.04%	57.51%	57.64%	61.61%	57.91%	61.81%
Operating Margin	25.11%	24.56%	25.90%	24.85%	28.08%	30.46%	29.17%	32.88%	31.54%	30.31%
EBIT Margin	25.13%	24.57%	25.91%	24.88%	29.67%	28.94%	29.18%	32.89%	28.95%	32.85%
Profit (Net Income) Margin	5.35%	4.40%	5.55%	11.40%	9.63%	5.71%	10.28%	13.28%	8.05%	10.34%
Tax Burden Percent	96.24%	95.89%	96.90%	98.31%	98.79%	97.31%	98.04%	98.54%	96.06%	98.06%
Interest Burden Percent	22.13%	18.68%	22.10%	46.60%	32.85%	20.26%	35.94%	40.96%	28.96%	32.11%
Effective Tax Rate	3.76%	4.11%	3.10%	1.69%	1.21%	2.69%	1.96%	1.46%	3.94%	1.94%
Return on Invested Capital (ROIC)	7.07%	6.61%	7.38%	8.43%	9.97%	10.06%	9.88%	11.58%	11.05%	11.19%
ROIC Less NNEP Spread (ROIC-NNEP)	5.40%	4.78%	5.61%	7.15%	8.16%	7.63%	8.13%	9.66%	8.83%	9.22%
Return on Net Nonoperating Assets (RNNOA)	38.28%	18.28%	37.14%	117.68%	219.86%	62.33%	138.35%	120.48%	147.32%	211.62%
Return on Equity (ROE)	45.35%	24.90%	44.52%	126.11%	229.82%	72.39%	148.23%	132.06%	158.37%	222.81%
Cash Return on Invested Capital (CROIC)	31.96%	9.88%	9.63%	-12.82%	-12.60%	7.06%	4.65%	6.28%	7.49%	10.96%
Operating Return on Assets (OROA)	6.20%	6.37%	7.09%	7.12%	8.95%	9.07%	9.39%	10.82%	9.77%	11.39%
Return on Assets (ROA)	1.32%	1.14%	1.52%	3.26%	2.90%	1.79%	3.31%	4.37%	2.72%	3.59%
Return on Common Equity (ROCE)	7.36%	-0.36%	-8.57%	-108.06%	-448.90%	-54.50%	-240.57%	-94.41%	-196.62%	-459.06%
Return on Equity Simple (ROE_SIMPLE)	-38.51%	0.00%	-22.56%	-25.22%	-25.45%	0.00%	-27.94%	-144.77%	-81.10%	0.00%
Net Operating Profit after Tax (NOPAT)	43	45	49	51	60	67	66	76	73	73
NOPAT Margin	24.17%	23.55%	25.10%	24.43%	27.74%	29.64%	28.59%	32.40%	30.29%	29.72%
Net Nonoperating Expense Percent (NNEP)	1.67%	1.83%	1.77%	1.28%	1.81%	2.42%	1.75%	1.92%	2.22%	1.97%
Return On Investment Capital (ROIC_SIMPLE)	-	2.25%	-	-	-	3.27%	-	-	-	3.09%
Cost of Revenue to Revenue	33.10%	34.71%	33.82%	33.79%	34.52%	32.52%	32.74%	33.22%	34.09%	-95.59%
SG&A Expenses to Revenue	8.16%	9.17%	9.69%	7.23%	9.25%	8.26%	9.96%	6.02%	6.40%	8.26%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	41.79%	40.73%	40.28%	41.35%	37.41%	37.02%	38.09%	33.90%	34.37%	165.28%
Earnings before Interest and Taxes (EBIT)	45	47	51	51	64	65	67	77	69	81
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	106	108	112	113	130	129	132	145	139	152
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.18	2.21	2.51	2.28	2.65	2.44	3.08	3.02	2.85	2.78
Price to Earnings (P/E)	0.00	0.00	0.00	469.69	142.73	100.66	66.11	48.58	42.28	32.23
Dividend Yield	13.98%	13.20%	11.13%	11.88%	9.81%	10.25%	8.04%	9.05%	9.38%	9.10%
Earnings Yield	0.00%	0.00%	0.00%	0.21%	0.70%	0.99%	1.51%	2.06%	2.37%	3.10%
Enterprise Value to Invested Capital (EV/IC)	1.76	1.68	1.75	1.79	1.96	1.94	2.15	2.08	2.06	2.10
Enterprise Value to Revenue (EV/Rev)	5.26	5.88	5.87	5.75	6.04	5.76	6.38	5.95	5.75	5.59
Enterprise Value to EBITDA (EV/EBITDA)	8.80	10.02	10.08	10.12	10.55	10.04	11.08	10.04	9.80	9.36
Enterprise Value to EBIT (EV/EBIT)	22.32	24.44	23.38	22.90	22.93	21.00	22.58	19.69	19.17	18.04
Enterprise Value to NOPAT (EV/NOPAT)	23.18	25.27	24.21	23.57	23.82	21.44	23.01	20.04	18.98	18.45
Enterprise Value to Operating Cash Flow (EV/OCF)	13.68	15.89	16.17	17.03	18.68	17.93	18.95	17.72	17.66	15.57
Enterprise Value to Free Cash Flow (EV/FCFF)	4.82	16.70	17.92	0.00	0.00	27.71	47.36	33.86	28.00	19.20
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-31.94	5.84	15.46	8.22	10.04	12.76	17.36	23.08	41.14	90.16
Long-Term Debt to Equity	-31.94	5.84	15.46	8.22	10.04	12.76	17.36	23.08	41.14	90.16
Financial Leverage	7.09	3.82	6.62	16.46	26.94	8.17	17.01	12.47	16.68	22.95
Leverage Ratio	9.60	5.22	8.18	21.05	33.29	9.93	19.35	14.63	19.12	26.01
Compound Leverage Factor	2.12	0.98	1.81	9.81	10.93	2.01	6.96	5.99	5.54	8.35
Debt to Total Capital	103.23%	85.37%	93.92%	89.16%	90.94%	92.73%	94.55%	95.85%	97.63%	98.90%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	103.23%	85.37%	93.92%	89.16%	90.94%	92.73%	94.55%	95.85%	97.63%	98.90%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	19.34%	13.37%	19.23%	19.07%	18.91%	16.56%	6.51%	6.51%	6.67%
Common Equity to Total Capital	-3.23%	-4.71%	-7.29%	-8.39%	-10.01%	-11.64%	-11.12%	-2.36%	-4.13%	-5.57%
Debt to EBITDA	5.15	5.10	5.05	5.03	4.90	4.81	4.87	4.63	4.64	4.41
Net Debt to EBITDA	5.15	5.10	5.05	5.03	4.90	4.81	4.87	4.63	4.64	4.41
Long-Term Debt to EBITDA	5.15	5.10	5.05	5.03	4.90	4.81	4.87	4.63	4.64	4.41
Debt to NOPAT	13.57	12.86	12.13	11.71	11.07	10.27	10.12	9.23	8.99	8.69
Net Debt to NOPAT	13.57	12.86	12.13	11.71	11.07	10.27	10.12	9.23	8.99	8.69
Long-Term Debt to NOPAT	13.57	12.86	12.13	11.71	11.07	10.27	10.12	9.23	8.99	8.69
Altman Z-Score	0.71	0.73	0.83	0.80	0.92	0.89	1.03	1.04	1.03	1.05
Noncontrolling Interest Sharing Ratio	83.77%	101.46%	119.24%	185.68%	295.32%	175.28%	262.30%	171.49%	224.16%	306.03%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.14	1.07	1.19	1.13	1.26	1.21	1.43	1.25	1.43	1.23
Quick Ratio	0.50	0.48	0.52	0.48	0.55	0.51	0.59	0.52	0.58	0.47
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	627	129	112	-426	-430	15	-60	-34	-18	62
Operating Cash Flow to CapEx	111.95%	188.60%	103.61%	136.34%	102.99%	115.57%	66.87%	200.95%	170.83%	458.09%
Free Cash Flow to Firm to Interest Expense	17.83	3.39	2.82	-10.13	-9.94	0.34	-1.15	-0.69	-0.37	1.27
Operating Cash Flow to Interest Expense	1.40	2.16	1.06	2.09	1.16	2.04	1.28	1.98	0.98	2.68
Operating Cash Flow Less CapEx to Interest Expense	0.15	1.02	0.04	0.56	0.03	0.28	-0.63	1.00	0.41	2.09
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.25	0.26	0.27	0.29	0.30	0.31	0.32	0.33	0.34	0.35
Accounts Receivable Turnover	7.19	7.15	7.56	7.44	9.17	9.44	9.65	9.26	9.13	10.30
Inventory Turnover	2.49	2.61	2.66	2.73	2.80	2.73	2.60	2.59	2.43	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	7.86	8.10	7.96	8.34	7.27	7.58	7.95	8.34	8.98	0.00
Days Sales Outstanding (DSO)	50.79	51.03	48.29	49.09	39.80	38.67	37.84	39.42	39.97	35.43
Days Inventory Outstanding (DIO)	146.69	139.85	137.39	133.46	130.37	133.64	140.51	140.92	149.92	0.00
Days Payable Outstanding (DPO)	46.46	45.05	45.86	43.79	50.18	48.13	45.91	43.77	40.65	0.00
Cash Conversion Cycle (CCC)	151.03	145.84	139.82	138.76	119.99	124.18	132.44	136.57	149.24	35.43
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,013	2,468	2,479	2,482	2,503	2,519	2,604	2,592	2,594	2,530
Invested Capital Turnover	0.29	0.28	0.29	0.34	0.36	0.34	0.35	0.36	0.36	0.38
Increase / (Decrease) in Invested Capital	-583	-84	-63	477	490	52	125	110	91	11
Enterprise Value (EV)	3,550	4,140	4,333	4,453	4,901	4,875	5,599	5,392	5,348	5,315
Market Capitalization	1,472	1,556	1,853	1,763	2,147	2,063	2,705	2,739	2,647	2,644
Book Value per Share	($0.66)	($1.19)	($1.71)	($2.12)	($2.55)	($2.98)	($2.82)	($0.52)	($0.92)	($1.21)
Tangible Book Value per Share	($3.55)	($3.99)	($4.44)	($4.77)	($5.12)	($5.48)	($5.15)	($2.50)	($2.83)	($3.05)
Total Capital	2,013	2,468	2,311	2,482	2,503	2,519	2,604	2,592	2,594	2,530
Total Debt	2,078	2,107	2,170	2,213	2,276	2,336	2,463	2,484	2,532	2,503
Total Long-Term Debt	2,078	2,107	2,170	2,213	2,276	2,336	2,463	2,484	2,532	2,503
Net Debt	2,078	2,107	2,170	2,213	2,276	2,336	2,463	2,484	2,532	2,503
Capital Expenditures (CapEx)	44	44	41	64	49	79	99	48	28	28
Debt-free, Cash-free Net Working Capital (DFCFNWC)	22	13	30	24	46	39	75	51	79	44
Debt-free Net Working Capital (DFNWC)	22	13	30	24	46	39	75	51	79	44
Net Working Capital (NWC)	22	13	30	24	46	39	75	51	79	44
Net Nonoperating Expense (NNE)	34	36	39	27	39	54	42	45	53	48
Net Nonoperating Obligations (NNO)	2,078	2,107	2,339	2,213	2,276	2,336	2,463	2,484	2,532	2,503
Total Depreciation and Amortization (D&A)	61	62	61	62	66	64	65	68	69	71
Debt-free, Cash-free Net Working Capital to Revenue	3.26%	1.81%	4.06%	3.11%	5.67%	4.60%	8.55%	5.65%	8.51%	4.66%
Debt-free Net Working Capital to Revenue	3.26%	1.81%	4.06%	3.11%	5.67%	4.60%	8.55%	5.65%	8.52%	4.66%
Net Working Capital to Revenue	3.26%	1.81%	4.06%	3.11%	5.67%	4.60%	8.55%	5.65%	8.52%	4.66%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.03)	($0.04)	($0.01)	$0.12	$0.09	$0.01	$0.19	$0.23	$0.13	$0.17
Adjusted Weighted Average Basic Shares Outstanding	97.97M	97.78M	98.25M	98.27M	98.29M	98.63M	102.54M	116.85M	117.02M	113.39M
Adjusted Diluted Earnings per Share	($0.03)	($0.04)	($0.01)	$0.11	$0.09	$0.01	$0.19	$0.23	$0.13	$0.17
Adjusted Weighted Average Diluted Shares Outstanding	97.97M	97.78M	98.25M	99.69M	100.26M	100.68M	103.61M	117.97M	118.26M	114.50M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	97.97M	97.78M	98.25M	98.27M	98.29M	98.63M	102.54M	116.85M	117.02M	113.39M
Normalized Net Operating Profit after Tax (NOPAT)	45	45	50	61	57	69	67	77	73	77
Normalized NOPAT Margin	25.04%	23.60%	25.50%	29.46%	26.38%	30.62%	29.13%	32.52%	30.24%	31.49%
Pre Tax Income Margin	5.56%	4.59%	5.73%	11.59%	9.75%	5.86%	10.49%	13.47%	8.38%	10.55%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.28	1.23	1.28	1.22	1.49	1.45	1.30	1.59	1.41	1.66
NOPAT to Interest Expense	1.24	1.18	1.24	1.20	1.39	1.49	1.27	1.56	1.47	1.50
EBIT Less CapEx to Interest Expense	0.03	0.08	0.26	-0.31	0.37	-0.32	-0.61	0.60	0.83	1.08
NOPAT Less CapEx to Interest Expense	-0.02	0.03	0.22	-0.33	0.27	-0.28	-0.64	0.58	0.90	0.92
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About USA Compression Partners' Financials

When does USA Compression Partners's fiscal year end?

According to the most recent income statement we have on file, USA Compression Partners' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has USA Compression Partners' net income changed over the last 9 years?

USA Compression Partners' net income appears to be on a downward trend, with a most recent value of $99.58 million in 2024, falling from -$154.27 million in 2015. The previous period was $68.27 million in 2023.

What is USA Compression Partners's operating income?

USA Compression Partners's total operating income in 2024 was $294.45 million, based on the following breakdown:

Total Gross Profit: $950.45 million
Total Operating Expenses: $656 million

How has USA Compression Partners revenue changed over the last 9 years?

Over the last 9 years, USA Compression Partners' total revenue changed from $270.55 million in 2015 to $950.45 million in 2024, a change of 251.3%.

How much debt does USA Compression Partners have?

USA Compression Partners' total liabilities were at $2.72 billion at the end of 2024, a 6.4% increase from 2023, and a 80.0% increase since 2015.

How much cash does USA Compression Partners have?

In the past 9 years, USA Compression Partners' cash and equivalents has ranged from $0.00 in 2021 to $4.01 million in 2017, and is currently $14 thousand as of their latest financial filing in 2024.

How has USA Compression Partners' book value per share changed over the last 9 years?

Over the last 9 years, USA Compression Partners' book value per share changed from 0.00 in 2015 to -1.21 in 2024, a change of -120.5%.

Remove Ads

Related Companies

This page (NYSE:USAC) was last updated on 4/16/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

USA Compression Partners (USAC) Financials

Frequently Asked Questions About USA Compression Partners' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

USA Compression Partners (USAC) Financials

Annual Income Statements for USA Compression Partners

Quarterly Income Statements for USA Compression Partners

Annual Cash Flow Statements for USA Compression Partners

Quarterly Cash Flow Statements for USA Compression Partners

Annual Balance Sheets for USA Compression Partners

Quarterly Balance Sheets for USA Compression Partners

Annual Metrics and Ratios for USA Compression Partners

Quarterly Metrics and Ratios for USA Compression Partners

Frequently Asked Questions About USA Compression Partners' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools